3 AI-Driven Medical Device Stocks to Watch in 2025
NVIDIA NVDA cofounded the Medical Open Network for AI ('MONAI') with the world's leading academic medical centers to establish an inclusive community of AI researchers, developing and exchanging best practices for AI in healthcare imaging across academia and enterprise researchers. Additionally, Gen AI powers real-time clinical documentation tools embedded within diagnostic devices, such as Nuance Communications's Dragon Ambient eXperience ('DAX'). These devices transcribe doctor-patient conversations into structured clinical notes, minimizing administrative burden and enhancing documentation accuracy.
Alternatively, agentic AI enables medical devices to act autonomously and make decisions based on real-time data. Agentic AI also supports predictive maintenance in connected medical equipment, such as MRIs and ventilators. This enables fault detection and automated service scheduling, thereby reducing equipment downtime. In the surgical field, AI-guided robotic systems, such as Intuitive Surgical's ISRG da Vinci platform, are integrating agentic AI features to assist with real-time tissue navigation and instrument movement.
Here, we have picked three medical devices stocks, namely Boston Scientific Corporation BSX, Johnson & Johnson JNJ and GE HealthCare Technologies Inc. GEHC, which are likely to perform well in 2025, driven by strong AI adoption.
Rising Demand for Precision and Personalized Medicine: AI enables medical devices to deliver highly individualized diagnostics and treatments. For instance, AI algorithms can analyze patient-specific imaging data or genetic profiles to guide the design of implants, surgical plans, or therapeutic regimens, improving patient outcomes.
Favorable Regulatory Environment: Regulatory oversight for AI in the United States falls under the FDA's Software as a Medical Device (SaMD) segment. Over 700 AI-enabled devices have been approved, which is more than 10 times the number available in 2020. In January, the FDA released a draft guidance on adaptive AI systems, which have reduced uncertainty for developers, encouraging innovation and faster approvals.
Boston Scientific is a major manufacturer of interventional medical devices. The company has been investing in AI to support its devices and improve procedural outcomes. It's HeartLogic is a heart failure diagnostic that utilizes AI to detect worsening heart failure in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). The Rhythm AI module in the Rhythmia HDx mapping system can automatically interpret electroanatomical maps to identify arrhythmia circuits, enabling electrophysiologists to target ablation therapy more effectively. Meanwhile, the company's Coronary Advanced Analysis software uses AI to analyze optical coherence tomography images to characterize plaque.
Boston Scientific, carrying a Zacks Rank #2 (Buy) at present, has a projected 2025 sales growth rate of 16.4%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 26.5% against the industry's -2.6%. For 2025, its earnings are expected to grow 15.9%.
Boston Scientific Corporation price | Boston Scientific Corporation Quote
Johnson & Johnson is a healthcare conglomerate with a major MedTech division (Johnson & Johnson MedTech) focused on medical devices and diagnostics. The company employs AI for surgical robotics, digital surgery analytics and imaging. It has developed an ecosystem called Ottava, its next-gen robotic surgery platform, and the Caresurgical/VELYS digital surgery systems, which use data and AI for procedure planning. Its Polyphonic Digital Ecosystem connects operating rooms, allowing surgeons to share live video and data with remote peers. AI in this system helps identify significant events in the surgery video feed for discussion.
Johnson & Johnson, carrying a Zacks Rank #2 at present, has a historical earnings growth rate of 5.5%, higher than the industry's 2.8%. The company has a net margin of 24.4%, outperforming the industry's 18.6%. For 2025, its sales are expected to grow 2.8%.
Johnson & Johnson price | Johnson & Johnson Quote
GE HealthCare is a global leader in medical imaging, diagnostics and healthcare. AI is central to the company's digital strategy, which focuses on its precision care framework. In 2023, it topped the FDA list of AI-enabled medical devices with 80 listed 510(k) clearances or authorizations to date in the United States. Recently, the company has launched CleaRecon DL — an AI-driven solution that enhances cone-beam computed tomography image quality. Also, its Invenia Automated Breast Ultrasound Premium, the latest 3D ultrasound, offers advanced AI and innovative features to drive faster, reproducible supplemental screening and streamline exam readings on patients with dense breasts.
GE HealthCare, carrying a Zacks Rank #3 (Hold) at present, has a projected 2025 sales growth rate of 3.2%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 9.7% against the industry's -2.6%.
GE HealthCare Technologies Inc. price | GE HealthCare Technologies Inc. Quote
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Call for Entries: Globee® Awards for Leadership to Recognize Achievements by Individuals and Teams
Recognizing Leadership at Every Level: 13th Annual Globee® Awards for Leadership Invites Entries from All Over the World SAN FRANCISCO, July 17, 2025 /PRNewswire/ -- The Globee® Awards, organizers of premier data-driven business awards programs with worldwide acceptance and industry-wide participation, have announced the Call for Entries for the 13th Annual Globee® Awards for Leadership, a global program dedicated to recognizing exceptional leadership achievements by individuals and teams. This program celebrates leaders at every level—those who inspire innovation, drive organizational success, and make a meaningful impact in their industries and communities. Organizations, leaders, and teams worldwide are invited to submit their accomplishments—whether local, regional, or global—for consideration. Learn more and submit your entries now: Winners are determined through a 100% merit-based process, with evaluations conducted by independent industry experts and peers from around the world. All judging scores are transparently shared with both winners and non-winners to ensure fairness and credibility. About the Globee® Awards The Globee® Awards present recognition across ten annual programs and competitions, celebrating achievements in business, innovation, technology, leadership, cybersecurity, artificial intelligence, and more. With global participation and evaluations from industry experts worldwide, the Globee® Awards have become a widely accepted standard for honoring excellence and impact across all sectors and organization sizes. To learn more about the Globee® Awards, please visit: Follow: @globeeawards | Hashtags: #globeeawards #leadershipawards #leadershipachievement #businessrecognition All trademarks belong to their respective owners. View original content to download multimedia: SOURCE Globee Awards
Fast Company
22 minutes ago
- Fast Company
Nvidia's power play: How Jensen Huang got Trump to rethink the China AI chip ban
Nvidia's Huang says chip bans aren't the way to deal with China Nvidia founder and CEO Jensen Huang has been active on the government relations and lobbying front, and now he's got something big to show for his efforts: the Trump Administration has agreed to lift a ban on selling Nvidia H20 AI chips to China. Huang met with leaders in both Washington and Beijing, arguing that the AI revolution is a tide that will lift all boats—that AI technology can boost business productivity, raise the standard of living, and improve GDP for both the U.S. and China. He emphasized that the best way for America to maintain an edge in the AI race is to ensure the world's AI models and apps run best on chips made by a U.S.-based company. The U.S. (under Biden) initially began restricting sales of Nvidia's most powerful chips to China in an effort to slow Beijing's AI ambitions. The Trump Administration later doubled down, effectively banning sales of the H20 back in April. As a result, Nvidia reported a loss of about $2.5 billion in sales during its quarter ending in April, and projected it would miss out on another $8 billion in the quarter ending in July. Huang apparently persuaded the Trump Administration to reverse course. His argument likely sounded something like this: 'Our mission, properly expressed, is that in order for America to have AI leadership is to make sure that the American tech stack is available to markets all over the world so that amazing developers, including the ones in China, are able to build on the American tech stack so that AI runs best on the American tech stack,' Huang said during a recent interview with CNN's Fareed Zakaria. Huang also noted that half of the world's AI researchers 'are in China and Chinese.' Huang seems to be suggesting that the U.S. can retain technological dominance by controlling the platform AI runs on—similar to how it maintains financial dominance by ensuring most world trade is based on the dollar. There may be some truth to that. But it raises important questions: What does such control actually mean? Will the U.S. be able to dictate how the Chinese use the chips? No—no more than it did when DeepSeek used the H20 to build its world-class models. Is Huang implying that the U.S. could collect information about Chinese AI activities through these chips (as the U.S. once accused China of doing through Huawei)? That seems very doubtful. There's no doubt that Nvidia and its shareholders benefit when the world's AI is built on its chips and software—but is America really better off? And if Huang truly believes the best AI chips shouldn't be restricted, doesn't it follow that he'll also ask the Trump Administration for permission to sell China its most powerful Blackwell chips, too? Fears grow that the U.S. government will use AI to surveille Six months into a chaotic second Trump presidency, new reports have emerged suggesting the government is increasingly interested in using AI tools to track and profile U.S. residents. According to multiple whistleblowers and insiders, agents of Elon Musk's DOGE are actively working to build a centralized, cross-agency database of Americans' personal information—some of it highly sensitive. The Washington Post reported in May that DOGE is rapidly constructing a centralized database that includes Social Security numbers, medical records, and tax files—doing so without regard for federal data privacy rules, and without standard oversight or even interagency agreements. From the outset, DOGE has pushed past barriers and sidelined individuals to gain access to data stored at the Treasury, Office of Personnel Management, Social Security Administration, Health and Human Services, and the Departments of Education and Labor, Meanwhile, concerns are also growing about how other agencies may be using AI to expand surveillance capabilities. ProPublica reported this week that the Internal Revenue Service is now developing a computer program that would give Immigration and Customs Enforcement (ICE) deportation officers unprecedented access to confidential tax data belonging to millions of American taxpayers, including their home addresses. In the past, ICE requested IRS data only for individuals it was actively investigating—typically no more than a dozen at a time. The new system could serve as a mass surveillance tool, possibly using AI, to identify new deportation targets. Due process may be a secondary concern. Adding to the unease, FedScoop reported last week that the General Services Administration is considering using an AI model developed by Elon Musk's xAI to process the personal data of American citizens. Palantir (cofounded by Trump ally Peter Thiel) has become deeply embedded within agencies across the federal government. Its AI is used for data integration, analysis, and decision-making at defense and intelligence agencies, as well as FEMA, ICE, and HHS. Critics have raised concerns about the breadth and depth of data Palantir can access, and the lack of transparency regarding how its systems function. After 9/11, Palantir began addressing the government's urgent need to make sense of the vast volumes of intelligence data it was collecting on potential terrorist operatives and events both domestically and abroad. Since then, the use of Palantir's platform has only grown—and it could easily be leveraged to form deep profiles on regular American citizens. AWS launches a one-stop shop for enterprise AI Agents Amazon's AWS cloud division is placing a big bet on AI agents. At this week's AWS Summit in New York City, the company unveiled 'AI Agents and Tools,' a new section within the AWS Marketplace designed as a kind of concierge service for businesses looking to buy, deploy, and manage AI agents. The store will feature agents from AWS, as well as third parties like Anthropic, IBM, Perplexity, and Salesforce. Typically, AI agents can store large amounts of information about a company and its workflows, and can reason through tasks. For existing AWS customers, the platform will likely simplify the process of integrating AI agents with AI models—allowing both to reside within the same secure cloud environment as their data. Amazon AWS is bundling everything companies need—databases, security tools, IT support, and deployment infrastructure—into one streamlined experience. Businesses will be able to describe their automation needs in plain English to an AI-powered search tool and receive customized recommendations on which agents are best suited for the job. Gartner predicts that agents will automate half of all business decisions by 2027. And no company wants to fall behind while competitors gain new efficiencies. However, building custom agents from scratch can be a major challenge for corporate IT departments, often requiring significant additional infrastructure and integration work. The new AWS agent platform and marketplace could help eliminate those hurdles. AWS is optimistic about the potential. 'It upends the way software is built,' said AWS VP for Agentic AI Swami Sivasubramanian at the announcement. 'It also introduces a host of new challenges to deploying and operating it, and potentially most impactfully, it changes how software interacts with the world—and how we interact with software.'
Yahoo
an hour ago
- Yahoo
SONAR Unveils Redesigned Supply Chain Intelligence Platform with New Risk and Efficiency Quadrant
A completely redesigned experience for SONAR's Supply Chain Intelligence (SCI) has been launched allowing SCI to deliver faster insights, deeper market intelligence, and more actionable guidance for shippers managing their RFPs. The updated platform merges the previous Opportunity View and List View into a single, powerful page called Lane View. This consolidation allows users to drill into lane-level insights efficiently, see market performance across both Intermodal and Truckload, and access pricing benchmarks, guidance, and scoring within one streamlined interface. Embedded in the new Lane View is a quadrant-based guidance system for risk and efficiency. This feature helps prioritize RFP strategy by categorizing lanes into four zones: High Risk Zone: Lanes that are difficult to cover and where you are over market. Carrier Dependent Zone: Lanes that are difficult to cover and where you are under market. Savings Opportunity: Lanes that are easy to cover where you are over market. Efficiency Zone: Top-performing lanes where you are under market and lanes are easy to cover. These zones highlight where to focus time, renegotiate, or reallocate volume. Additionally, the update introduces enhanced Summary and Network Views for sharper high-level visibility. Users can better understand where they are overpaying or underpaying across their network with clearer visuals and aggregated scoring. New market-level maps and improved filters help spot areas of concern or opportunity and enable faster diagnostics. The new SCI helps unlock greater RFP savings and lane performance with smarter, visual prioritization, allowing users to reduce risk, boost service, and easily spot network inefficiencies. To explore the redesigned experience, log in to SONAR and navigate to the SCI module. For a personalized walkthrough, contact your account manager or cs@ To learn more about SONAR, visit and request a demo. The post SONAR Unveils Redesigned Supply Chain Intelligence Platform with New Risk and Efficiency Quadrant appeared first on FreightWaves. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
